Reuters logo
8 个月前
BRIEF-Mallinckrodt will initiate company-sponsored clinical trial of h.p. acthar gel in treatment of amyotropic lateral sclerosis
2016年11月21日 / 下午12点42分 / 8 个月前

BRIEF-Mallinckrodt will initiate company-sponsored clinical trial of h.p. acthar gel in treatment of amyotropic lateral sclerosis

1 分钟阅读

Nov 21 (Reuters) - Mallinckrodt Plc :

* Study is expected to begin in first half of 2017

* Says U.S. Fda has granted co's request for a fast track designation for its acthar investigational new drug (IND) application in patients with ALS

* Mallinckrodt will initiate company-sponsored clinical trial of h.p. acthar gel in treatment of amyotropic lateral sclerosis (als) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below